SOURCE: ZYTO Corp

ZYTO Corp

November 14, 2012 17:41 ET

ZYTO Reports Record Third Quarter Results

Third Consecutive Quarter of Net Income

LINDON, UT--(Marketwire - Nov 14, 2012) - ZYTO Corp (OTCBB: ZYTO) (www.ZYTO.com).

ZYTO Corp, a Utah-based biotech company specializing in biocommunication applications, today reported net income of $97,613 for the third quarter of 2012, compared to a net loss of $28,397 for the same quarter last year, reflecting an increase of $126,010. Total revenues for the third quarter of 2012 increased 18.8% to $1.18 million from $1.0 million in the same quarter last year.

The Company also reported net income of $194,467 for the nine months ended September 30, 2012, compared to a net loss of $425,787 for the same period last year, reflecting an increase of $620,254.

"I'm especially pleased with our record growth because this means more individuals are benefiting from ZYTO technology in their pursuit of better health," said Chairman and Chief Executive Officer, Dr. Vaughn R Cook. "We are truly making a difference in people's lives throughout the world."

"We continue to see an increase in our product sales and subscriptions," said Brian E. Halladay, Chief Financial Officer. "We have made significant enhancements to our current software, leading to higher customer satisfaction, and increased referrals. This has positively increased our bottom line results."

About ZYTO Corp

ZYTO Corp was founded by its CEO Dr. Vaughn R Cook, OMD. The company designs and builds computer biocommunication technology to facilitate decision making about healthcare and wellness options.

For more information and to receive a copy of the Company's Quarterly Report, visit www.ZYTO.com or contact their Headquarters at 801-224-7199.

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to marketing and sales activities by ZYTO's marketing partners, ZYTO product development launches, future growth and research, and enhanced value for ZYTO's stockholders are forward-looking statements. Such forward-looking statements involve risks and uncertainties, including, without limitation, continued acceptance of the Company's products, increased levels of competition, new products and technological changes, dependence upon third-party suppliers, intellectual property rights, and other risks detailed from time to time in the Company's periodic reports filed with the U.S. Securities and Exchange Commission. ZYTO disclaims any obligation or intention to update any forward-looking statement contained in this release.

Contact Information